Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
about
Marburg virus infection detected in a common African batMarburgvirus genomics and association with a large hemorrhagic fever outbreak in AngolaMolecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequencesElectron tomography reveals the steps in filovirus buddingBench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentationRisk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysisFiloviruses in bats: current knowledge and future directionsHow severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence"Filoviruses": a real pandemic threat?Potential for introduction of bat-borne zoonotic viruses into the EU: a reviewClinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008Response to imported case of Marburg hemorrhagic fever, the NetherlandFactors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola.Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007.Infection control during filoviral hemorrhagic Fever outbreaks.Characterization of monoclonal antibodies to Marburg virus nucleoprotein (NP) that can be used for NP-capture enzyme-linked immunosorbent assay.Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation.Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.Transmission potential and design of adequate control measures for Marburg hemorrhagic feverFilovirus emergence and vaccine development: a perspective for health care practitioners in travel medicineEffectiveness of traveller screening for emerging pathogens is shaped by epidemiology and natural history of infectionAntibody-dependent enhancement of Marburg virus infectionClinical aspects of Marburg hemorrhagic feverA review of epidemiological parameters from Ebola outbreaks to inform early public health decision-makingRisk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol ExposureSerosurvey on household contacts of Marburg hemorrhagic fever patientsPotential mammalian filovirus reservoirs.Ebola in the context of conflict affected states and health systems: case studies of Northern Uganda and Sierra Leone.High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.The evolving field of biodefence: therapeutic developments and diagnostics.Development of a model for marburgvirus based on severe-combined immunodeficiency mice.Does the impact of biodiversity differ between emerging and endemic pathogens? The need to separate the concepts of hazard and risk.Forty-five years of Marburg virus research.Development of vaccines for Marburg hemorrhagic fever.Protection against filovirus infection: virus-like particle vaccines.Marburg- and Ebolaviruses: A Look Back and Lessons for the Future.Ebola Virus Disease in Humans: Pathophysiology and Immunity.[Bats and other reservoir hosts of Filoviridae. Danger of epidemic on the African continent?--a deductive literature analysis].Budding of Marburgvirus is associated with filopodia.
P2860
Q21090111-01BA4BE3-DD4D-4FCD-AF72-0D19F321264BQ24548936-64C65617-076C-4247-8899-7CE4843BB162Q24621020-2AE67FC7-5C40-4FBB-BA21-A843F110DF72Q27314945-C76DA04F-85AD-4CDF-A3CB-65462BC2A80BQ28386164-BE11273D-79DB-4AFA-9092-73FF2427DA7DQ28389947-667633EB-5179-4401-AE52-D940FA54B56BQ28657754-3CB1CE1C-6F81-4488-8642-E7DF3A7589E6Q30151580-C1D56681-1AE4-4BC5-BE88-4662827D6414Q30384090-F4E8E552-A570-4DC6-8D20-8D10882E484DQ30391636-2FA51C8F-4559-42F5-8A4C-280B23A8D157Q30584295-8325EE9F-AB72-4192-BF02-E1A44FFE1927Q33502911-62038432-EC6C-41D8-86B5-54A14498027CQ33571462-667E250D-6BF3-4865-9C91-6CF42CF9FAA4Q34028916-7A6EF769-968D-482A-9E2D-3174F5E7E2AEQ34243483-0B4F3DA9-0732-4134-95D6-241DE5203F98Q34404757-5FDEE278-7813-4511-A20A-DEC8E7BE303FQ34484140-13EBF639-5A04-46B3-808C-4AD5694A7455Q34512045-C2A44D6B-8004-4658-B38D-B47735EF10D3Q34515978-13DFE48B-D1DD-44F9-8ECA-17F509F8CEE0Q35048254-ECACD216-332D-4389-B93C-E558F966D033Q35111513-A8D47B0E-BFB6-4FF8-A487-ED931BE9A739Q35299989-58093535-E6EE-4CC5-BDDC-95976CE7E40CQ35446144-5E774AB0-376A-4648-BAE8-548A46326642Q35646993-B13B430E-B9E3-4B25-AB27-8F2C998613A9Q35654347-7CA110D4-0908-42BE-AEA1-3F4A2D51D23FQ35790316-6B699196-EC44-446F-BEB7-2FC0468C9347Q35793913-706AC099-7A64-4598-AA92-9E9A0952A488Q35881119-53E15070-6BA8-483C-AAE2-9C8398D075CEQ35930048-A83DB64C-F148-48BA-A476-2A9EA6A006CFQ36048772-50DA7685-C7A3-4BA7-BB70-77E6ADC511CAQ36085668-F178E8AC-F22F-47A0-9D47-6CFB21BE2801Q36310674-901A3C9F-EC75-429C-99B0-FADD3CE4F946Q36355715-023BAF81-E157-498B-8D9A-55DB9D58FEC8Q36395831-C665A1A5-B345-4C36-AF51-5F4EF8367167Q36728793-BDE422BF-73E5-4D67-BC00-3CA8D40258E5Q37130463-47ABB4EE-AA50-4F75-BF68-8BC041B7534FQ38675825-5E574EBF-C88E-4B42-8735-7B346C2AF4CCQ38707770-D3EA3884-A6A5-4F4D-B654-F8BC43F2DCF9Q38871691-DCED61E9-BA2C-457D-BF6C-0B3E3101F780Q40202125-23BBF159-42D5-4DA7-AE37-0918B772C2B0
P2860
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@ast
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@en
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@nl
type
label
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@ast
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@en
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@nl
prefLabel
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@ast
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@en
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@nl
P2093
P2860
P50
P356
P1476
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
@en
P2093
Antoine Talarmin
Ben Tugume
Cathy Roth
Daniel G Bausch
Eric Bertherat
Guénaël R Rodier
Kader M Kondé
Loku L Olinda
Matthias Borchert
Modeste L Libande
P2860
P304
P356
10.3201/EID0912.030355
P50
P577
2003-12-01T00:00:00Z